These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 15832426)

  • 1. Effects of dendritic cells from cord blood CD34+ cells on human hepatocarcinoma cell line BEL-7402 in vitro and in SCID mice.
    Su ZJ; Chen HB; Zhang JK; Xu L
    World J Gastroenterol; 2005 Apr; 11(16):2502-7. PubMed ID: 15832426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activities of human dendritic cells derived from peripheral and cord blood.
    Zhang JK; Li J; Chen HB; Sun JL; Qu YJ; Lu JJ
    World J Gastroenterol; 2002 Feb; 8(1):87-90. PubMed ID: 11833078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dendritic cell-based immunotherapy produced from cord blood in vitro and in a humanized NSG mouse cancer model.
    Liu G; Fan X; Cai Y; Fu Z; Gao F; Dong J; Li K; Cai J
    Immunotherapy; 2019 May; 11(7):599-616. PubMed ID: 30943862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of dendritic-based vaccine efficacy against hepatitis B virus-related hepatocellular carcinoma by two tumor-associated antigen gene-infected dendritic cells.
    Yang JY; Cao DY; Xue Y; Yu ZC; Liu WC
    Hum Immunol; 2010 Mar; 71(3):255-62. PubMed ID: 20036295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.
    Li X; Zhang Z; Lin G; Gao Y; Yan Z; Yin H; Sun B; Wang F; Zhang H; Chen H; Cao D
    Tumour Biol; 2016 Aug; 37(8):11267-78. PubMed ID: 26951511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The study on specific umbilical blood Dc vaccine for Beige nude mice loaded human colorectal carcinoma to induce anti-tumor immunity.
    Fu ZX; Han JS; Liu F; Zhao ZL; Li DB; Shi L; Dong JT; Zhou Y; Cai JH
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2364-2371. PubMed ID: 28617554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An in vitro study of specific antitumor immunity induced by dendritic cells pulsed with tumor cell lysates from patients with hepatocellular carcinoma].
    Gao J; Chen M; Peng ML; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):198-201. PubMed ID: 15760555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effects and mechanisms of a dendritic cell vaccine which silenced SOCS1 by siRNA, stimulated by OK-432 and pulsed with lysate of HepG2 cells].
    Song HF; Zhou J; Pan K; Wang QJ; Wang H; Huang LX; Li YQ; Xia JC
    Ai Zheng; 2008 Jul; 27(7):685-91. PubMed ID: 18606059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC.
    Han Q; Wang Y; Pang M; Zhang J
    J Exp Clin Cancer Res; 2017 Nov; 36(1):156. PubMed ID: 29115974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination with dendritic cells pulsed with apoptotic cells elicits effective antitumor immunity in murine hepatoma models.
    Hayashi T; Nakao K; Nagayama Y; Saitoh O; Ichikawa T; Ishikawa H; Hamasaki K; Eguchi K; Ishii N
    Int J Oncol; 2005 May; 26(5):1313-9. PubMed ID: 15809723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma.
    Zhang Y; Xie F; Yin Y; Zhang Q; Jin H; Wu Y; Pang L; Li J; Gao J
    Int J Nanomedicine; 2021; 16():1553-1564. PubMed ID: 33658783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor effects of fusion vaccine prepared by renal cell carcinoma 786-O cell line and peripheral blood dendritic cells of healthy volunteers in vitro and in human immune reconstituted SCID mice.
    Hu Z; Liu S; Mai X; Hu Z; Liu C
    Cell Immunol; 2010; 262(2):112-9. PubMed ID: 20167310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of HBsAg gene-modified dendritic cell-based vaccine efficacy by optimizing immunization method or the application of β-glucosylceramide.
    Long J; Zhou B; Li H; Dai Q; Zhang B; Xing S; Zeng Z; Chen W; Yang J
    Immunol Invest; 2013; 42(2):137-55. PubMed ID: 23323523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo anti-tumor effect of hybrid vaccine of dendritic cells and esophageal carcinoma cells on esophageal carcinoma cell line 109 in mice with severe combined immune deficiency.
    Guo GH; Chen SZ; Yu J; Zhang J; Luo LL; Xie LH; Su ZJ; Dong HM; Xu H; Wu LB
    World J Gastroenterol; 2008 Feb; 14(8):1167-74. PubMed ID: 18300341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell-based vaccine targeting aspartate-β-hydroxylas represents a promising therapeutic strategy for HCC.
    Zhou Y; Li C; Shi G; Xu X; Luo X; Zhang Y; Fu J; Chen L; Zeng A
    Immunotherapy; 2019 Nov; 11(16):1399-1407. PubMed ID: 31608722
    [No Abstract]   [Full Text] [Related]  

  • 18. Autologous Tumor Cell Lysate-Loaded Dendritic Cell Vaccine Inhibited Tumor Progression in an Orthotopic Murine Model for Hepatocellular Carcinoma.
    Wang Q; Luan W; Warren L; Kadri H; Kim KW; Goz V; Blank S; Isabel Fiel M; Hiotis SP
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):574-582. PubMed ID: 26786094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells.
    Choi YJ; Park SJ; Park YS; Park HS; Yang KM; Heo K
    PLoS One; 2018; 13(1):e0190638. PubMed ID: 29298343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
    Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
    Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.